A Study of Setrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Genotype 1 Chronic Hepatitis C
Clinical trial NCT01903954 · COMPLETED
Trial details
- NCT number
- NCT01903954
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2013-05-01
- Enrollment
- 283
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.